Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Viela Bio

Viela Bio
PRIVATE STATUS
Series A LATEST DEAL TYPE
$282M LATEST DEAL AMOUNT
5 INVESTORS
Description

Operator of a clinical-stage biotechnology firm intended to offer treatments for severe inflammation and autoimmune diseases. The company's clinical-stage biotechnology firm offers treatment for a portfolio of critical pathways that are the root cause of disease.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • One MedImmune Way
  • Fifth Floor, Suite Area Two
  • Gaithersburg, MD 20878
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Viela Bio’s full profile, request a free trial.

Viela Bio Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 13-Mar-2018 $282M 00000 00000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Viela Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A3 0,000,000 00.000000 000 000 00 000 00
Series A2 00,000,000 00.000000 000 000 00 000 00.000
Series A1 14,225,324 $0.001000 $10 $10 1x $10 44.84%
To view this company’s complete Cap Table, request access »

Viela Bio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
6 Dimensions Capital Venture Capital Minority 000 0000 000000 0
Boyu Capital Advisory Company PE/Buyout Minority 000 0000 000000 0
Hillhouse Capital Group Venture Capital Minority 000 0000 000000 0
Sirona Capital PE/Buyout Minority 000 0000 000000 0
Temasek Holdings Sovereign Wealth Fund Minority 000 0000 000000 0

Viela Bio Executive Team (6)

Name Title Board
Seat
Contact
Info
Matt Pietras Senior Director, Controller and Treasurer
Soraya Madani Ph.D Vice President & Head of Portfolio Management and Regulatory Affairs
Jorn Drappa Ph.D Chief Medical Officer & Head of Research & Development
Aaron Ren Ph.D Head of Business Development and Operations
Eliezer Katz MD Vice President of Clinical Development
You’re viewing 5 of 6 executives. Get the full list »

Viela Bio Board Members (2)

Name Representing Role Since Contact
Info
Yanling Cao Boyu Capital Advisory Company Board Member 000 0000
Zhengbin Yao Ph.D Self Chief Executive Officer & Board Member 000 0000